CLEVELAND, Jan. 5, 2011 /PRNewswire/ -- RSB Spine, LLC, a medical device company focused on developing unique modular spinal fusion products for surgical treatment of degenerative disc disease, today announced a 97% sales increase for 2010 versus 2009, with a 184% sales increase for the fourth quarter of 2010 versus the prior-year period. The company also reports an average growth rate of 33% for five sequential quarters.
RSB Spine Chief Executive Officer John A. Redmond said: "It was a very challenging year for implant companies, and our strong finish and consecutive quarterly growth are a direct result of unique products, great employees and stellar execution by our master distributor Paradigm BioDevices. Our accomplishments in 2010 position us to achieve our strategic goals for 2011."
"The InterPlate® platform is gaining rapid market acceptance due to the unique selection of implants available," said Mike O'Neill President & Chief Executive Officer of Paradigm BioDevices. "For the first time surgeons have the freedom to select the flush-fit interbody construct they want and to determine how that construct will behave. We do not box our surgeons into an implant technology with limited options."